[EN] TREATMENT OF CDK4/6 INHIBITOR RESISTANT NEOPLASTIC DISORDERS<br/>[FR] TRAITEMENT DE TROUBLES NÉOPLASIQUES RÉSISTANT AUX INHIBITEURS DE CDK4/6
申请人:G1 THERAPEUTICS INC
公开号:WO2020206035A1
公开(公告)日:2020-10-08
This invention is to methods for treating disorders involving abnormal cellular proliferation that have developed resistance to a selective CDK4/6 inhibitor.